The Interaction of Charged and Uncharged Drugs with Neutral (HP-β-CD) and Anionically Charged (SBE7-β-CD) β-Cyclodextrins
暂无分享,去创建一个
Valentino J. Stella | Roger A. Rajewski | V. Stella | K. Uekama | R. Rajewski | Kaneto Uekama | J. Jona | K. Okimoto | Kazuto Okimoto | Janan A. Jona
[1] K. A. Connors,et al. Effect of cycloamyloses on apparent dissociation constants of carboxylic acids and phenols: equilibrium analytical selectivity induced by complex formation. , 1976, Journal of pharmaceutical sciences.
[2] T. Higuchi,et al. Phase solubility techniques , 1965 .
[3] V. Stella,et al. The effect of SBE4-β-CD on i.m. prednisolone pharmacokinetics and tissue damage in rabbits: Comparison to a co-solvent solution and a water-soluble prodrug , 1995 .
[4] V. Stella,et al. Differential Effects of Sulfate and Sulfobutyl Ether of β-Cyclodextrin on Erythrocyte Membranes in Vitro , 2004, Pharmaceutical Research.
[5] Valentino J. Stella,et al. β‐Cyclodextrin Derivatives, SBE4‐β‐CD and HP–β‐CD, Increase the Oral Bioavailability of Cinnarizine in Beagle Dogs , 1995 .
[6] D. Duchěne,et al. Indomethacin and cyclodextrin complexes , 1991 .
[7] A. Urtti,et al. Sulfobutyl ether β-cyclodextrin (SBE-β-CD) in eyedrops improves the tolerability of a topically applied pilocarpine prodrug in rabbits , 1995 .
[8] B. Müller,et al. Interaction of NSA with cyclodextrins and hydroxypropyl cyclodextrin derivatives , 1991 .
[9] D Wouessidjewe,et al. High-field nuclear magnetic resonance techniques for the investigation of a beta-cyclodextrin:indomethacin inclusion complex. , 1990, Journal of pharmaceutical sciences.
[10] T. Nagai,et al. Inclusion complexes of cinnarizine with beta-cyclodextrin in aqueous solution and in the solid state. , 1984, Chemical & pharmaceutical bulletin.
[11] K. A. Connors,et al. Potentiometric study of molecular complexes of weak acids and bases applied to complexes of alpha-cyclodextrin with para-substituted benzoic acids. , 1982, Journal of pharmaceutical sciences.
[12] D. Bindra,et al. Effect of SBE4-β-CD, a sulfobutyl ether β-cyclodextrin, on the stability and solubility of O6-benzylguanine (NSC-637037) in aqueous solutions , 1995 .
[13] B. D. Anderson,et al. Solubilization of a tripeptide HIV protease inhibitor using a combination of ionization and complexation with chemically modified cyclodextrins. , 1994, Journal of pharmaceutical sciences.
[14] K. A. Connors,et al. trans-Cinnamic acid--alpha-cyclodextrin system as studied by solubility, spectral, and potentiometric techniques. , 1980, Journal of pharmaceutical sciences.
[15] A. Scarpellini,et al. Formation and antimycotic effect of cyclodextrin inclusion complexes of econazole and miconazole , 1993 .
[16] V. Stella,et al. Preliminary safety evaluation of parenterally administered sulfoalkyl ether beta-cyclodextrin derivatives. , 1995, Journal of pharmaceutical sciences.
[17] N. Bodor,et al. The potential use of cyclodextrins in parenteral formulations. , 1989, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.
[18] M A Mintun,et al. Dissolution kinetics of carboxylic acids I: effect of pH under unbuffered conditions. , 1981, Journal of pharmaceutical sciences.
[19] S. Pedersen,et al. Polymorphism of miconazole during preparation of solid systems of the drug and β-cyclodextrins , 1993 .
[20] Valentino J. Stella,et al. The effect of SBE4-β-CD on i.v. methylprednisolone pharmacokinetics in rats: Comparison to a co-solvent solution and two water-soluble prodrugs , 1995 .
[21] V. Stella,et al. The effect of a modified beta-cyclodextrin, SBE4-beta-CD, on the aqueous stability and ocular absorption of pilocarpine. , 1994, Current eye research.
[22] V. Stella,et al. Characterization of sulphoalkyl ether derivatives of beta-cyclodextrin by capillary electrophoresis with indirect UV detection. , 1992, Journal of pharmaceutical and biomedical analysis.
[23] J. Pitha. Amorphous water-soluble derivatives of cyclodextrins: nontoxic dissolution enhancing excipients. , 1985, Journal of pharmaceutical sciences.
[24] Kap Lim,et al. Solubilization of Thiazolobenzimidazole Using a Combination of pH Adjustment and Complexation with 2-Hydroxypropyl-β-Cyclodextrin , 1993, Pharmaceutical Research.
[25] A. Mitra,et al. Cyclodextrin/Weak-Electrolyte Complexation: Interpretation and Estimation of Association Constants from Phase Solubility Diagrams , 1992, Pharmaceutical Research.